0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Blood & Plasma Components Market by Product Type, Application, End User, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 180 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010964
UP TO EUR$697USDGBP OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Blood & Plasma Components Market forms a critical backbone for healthcare systems worldwide, supporting everything from routine transfusions to cutting-edge therapeutic interventions. As demand rises and supply chains evolve, senior decision-makers must stay ahead of regulatory, technological, and operational trends shaping this sector.

Market Snapshot: Blood & Plasma Components Market Overview

The Blood & Plasma Components Market grew from USD 45.86 billion in 2024 to USD 48.62 billion in 2025. It is expected to continue growing at a CAGR of 5.75%, reaching USD 64.15 billion by 2030. This robust trajectory reflects continued innovation in supply chain management, product development, and compliance. The blood & plasma components market is characterized by strong cross-sector partnerships, investments in local manufacturing, and increasing digitalization in both donor recruitment and distribution.

Scope & Segmentation

This report gives senior leaders a detailed breakdown of the market’s core structure, shining a light on product, application, end-user, distribution, and regional nuances. Segmentation is as follows:

  • Product Type: Plasma proteins, including albumin, coagulation factors (Factor IX, Factor VIII, Prothrombin Complex Concentrates), and immunoglobulins (intravenous and subcutaneous forms); platelets; red blood cells; white blood cells.
  • Application: Diagnostic, research, and therapeutic uses—each with distinct regulatory standards and usage drivers.
  • End User: Diagnostic laboratories, hospitals (ambulatory surgical centers, government hospitals, private hospitals), and research institutions using these products to serve varied clinical and innovation needs.
  • Distribution Channel: Hospital pharmacies, online pharmacies, and retail pharmacies—indicating diversification in how these components reach health institutions and patients.
  • Regional Coverage: Americas (including the US, Canada, Mexico, and key South American markets), Europe, Middle East & Africa (spanning major economies such as the UK, Germany, France, and many others), and Asia-Pacific (with representation from China, India, Japan, Australia, and additional regional leaders).
  • Key Companies: Coverage includes leading global providers of blood and plasma components, such as CSL Limited, Grifols, Takeda Pharmaceutical Company, Octapharma, Biotest, KEDRION, Shanghai RAAS Blood Products, Bio Products Laboratory, LFB, and Sanquin Blood Supply Foundation.

Key Takeaways for Senior Decision-Makers

  • Technological innovation—including advanced plasmapheresis and purification platforms—continues to raise both efficiency and safety benchmarks for collection, processing, and storage.
  • Digital solutions are integral to recruitment, supply chain visibility, and predictive analytics, supporting more agile, demand-driven management across every market segment.
  • Complex regulatory frameworks and heightened standards for donor eligibility, safety, and pathogen reduction require adaptable operational models and greater investment in compliance.
  • Strategic alliances and cross-sector partnerships are becoming central to securing reliable plasma sources and accelerating therapeutic innovation.
  • Regional strategies must reflect diverse infrastructure, economic incentives, and policy environments; local manufacturing and technology transfer are emerging as key growth levers, particularly in Asia-Pacific.

Assessing United States Tariff Impact

New tariffs introduced in the United States in 2025 have significantly influenced the cost structure throughout the blood and plasma product value chain. Incremental import duties on reagents and equipment have driven up production costs and triggered a shift towards domestic sourcing and innovation. Some organizations have adapted through vertical integration and partnerships, while others encounter pricing and supply constraints. Success in this tariff environment requires revised negotiation and procurement strategies, as well as ongoing engagement with both domestic and international stakeholders.

Methodology & Data Sources

This market analysis is grounded in primary interviews with industry leaders, plasma specialists, and healthcare providers, and further validated through secondary research from regulatory disclosures and scientific literature. Quantitative assessment was achieved via triangulation of proprietary databases with public data. External subject-matter experts provided additional validation, ensuring a reliable evidence base.

Why This Report Matters

  • Gives executives a clarity on growth pathways, helping identify optimal investment and partnership opportunities in the blood & plasma components market.
  • Offers a granular, actionable framework for aligning business strategy with market realities across products, regions, and regulatory matrices.

Conclusion

The Blood & Plasma Components Market demands strategic agility, investment in digital and operational innovation, and cross-functional leadership. This report equips stakeholders to meet evolving marketplace challenges, optimize supply chains, and capture emerging opportunities with confidence.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Blood & Plasma Components Market, by Product Type
8.1. Introduction
8.2. Plasma Proteins
8.2.1. Albumin
8.2.2. Coagulation Factors
8.2.2.1. Factor IX
8.2.2.2. Factor VIII
8.2.2.3. Prothrombin Complex Concentrates
8.2.3. Immunoglobulins
8.2.3.1. Intravenous Immunoglobulin
8.2.3.2. Subcutaneous Immunoglobulin
8.3. Platelets
8.4. Red Blood Cells
8.5. White Blood Cells
9. Blood & Plasma Components Market, by Application
9.1. Introduction
9.2. Diagnostic
9.3. Research
9.4. Therapeutic
10. Blood & Plasma Components Market, by End User
10.1. Introduction
10.2. Diagnostic Laboratories
10.3. Hospitals
10.3.1. Ambulatory Surgical Centers
10.3.2. Government Hospitals
10.3.3. Private Hospitals
10.4. Research Institutions
11. Blood & Plasma Components Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.4. Retail Pharmacies
12. Americas Blood & Plasma Components Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Blood & Plasma Components Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Blood & Plasma Components Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. CSL Limited
15.3.2. Grifols, S.A.
15.3.3. Takeda Pharmaceutical Company Limited
15.3.4. Octapharma AG
15.3.5. Biotest AG
15.3.6. KEDRION S.p.A.
15.3.7. Shanghai RAAS Blood Products Co., Ltd
15.3.8. Bio Products Laboratory Limited
15.3.9. LFB S.A.
15.3.10. Sanquin Blood Supply Foundation
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BLOOD & PLASMA COMPONENTS MARKET MULTI-CURRENCY
FIGURE 2. BLOOD & PLASMA COMPONENTS MARKET MULTI-LANGUAGE
FIGURE 3. BLOOD & PLASMA COMPONENTS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BLOOD & PLASMA COMPONENTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BLOOD & PLASMA COMPONENTS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BLOOD & PLASMA COMPONENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY ALBUMIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY FACTOR IX, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY FACTOR VIII, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLATELETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY RED BLOOD CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY WHITE BLOOD CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 56. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 57. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 58. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 59. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 60. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 63. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 65. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 66. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 67. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 68. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 71. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 104. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 106. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 107. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 108. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 109. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 112. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 114. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 115. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 116. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 117. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 120. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 128. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 130. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 131. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 132. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 133. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 136. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 138. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 139. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 140. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 141. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 144. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 152. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. SAUDI ARABIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 169. DENMARK BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 170. DENMARK BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 171. DENMARK BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 172. DENMARK BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 173. DENMARK BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. DENMARK BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. DENMARK BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 176. DENMARK BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. NETHERLANDS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 178. NETHERLANDS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 181. NETHERLANDS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. NETHERLANDS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. NETHERLANDS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 184. NETHERLANDS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. QATAR BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 186. QATAR BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 187. QATAR BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 188. QATAR BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 189. QATAR BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. QATAR BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. QATAR BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 192. QATAR BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 193. FINLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 194. FINLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 195. FINLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 196. FINLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 197. FINLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. FINLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. FINLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 200. FINLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. SWEDEN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 202. SWEDEN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 203. SWEDEN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 204. SWEDEN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 205. SWEDEN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. SWEDEN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. SWEDEN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. NIGERIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 216. NIGERIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 217. EGYPT BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 218. EGYPT BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 219. EGYPT BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 220. EGYPT BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 221. EGYPT BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. EGYPT BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. EGYPT BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 224. EGYPT BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 225. TURKEY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 226. TURKEY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 227. TURKEY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 228. TURKEY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 229. TURKEY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. TURKEY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 231. TURKEY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 232. TURKEY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 233. ISRAEL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 234. ISRAEL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 235. ISRAEL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 236. ISRAEL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 237. ISRAEL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. ISRAEL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. ISRAEL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 240. ISRAEL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 241. NORWAY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 242. NORWAY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 243. NORWAY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 244. NORWAY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 245. NORWAY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 246. NORWAY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 247. NORWAY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 248. NORWAY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 249. POLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 250. POLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 251. POLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 252. POLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 253. POLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. POLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. POLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 256. POLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 272. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 274. CHINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 275. CHINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 276. CHINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 277. CHINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 278. CHINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. CHINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. CHINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 281. CHINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 282. INDIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 283. INDIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 284. INDIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 285. INDIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 286. INDIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 287. INDIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 288. INDIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 289. INDIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 290. JAPAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 291. JAPAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 292. JAPAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 293. JAPAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 294. JAPAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 295. JAPAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 296. JAPAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 297. JAPAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 298. AUSTRALIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 299. AUSTRALIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 300. AUSTRALIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 301. AUSTRALIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 302. AUSTRALIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 303. AUSTRALIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 304. AUSTRALIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 305. AUSTRALIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 306. SOUTH KOREA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 307. SOUTH KOREA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 308. SOUTH KOREA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 309. SOUTH KOREA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 310. SOUTH KOREA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 311. SOUTH KOREA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 312. SOUTH KOREA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 313. SOUTH KOREA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 314. INDONESIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 315. INDONESIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2030 (USD MILLION)
TABLE 316. INDONESIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, 2018-2030 (USD MILLION)
TABLE 317. INDONESIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2030 (USD MILLION)
TABLE 318. INDONESIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 319. INDONESIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 320. INDONESIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 321. INDONESIA BLOOD

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Blood & Plasma Components market report include:
  • CSL Limited
  • Grifols, S.A.
  • Takeda Pharmaceutical Company Limited
  • Octapharma AG
  • Biotest AG
  • KEDRION S.p.A.
  • Shanghai RAAS Blood Products Co., Ltd
  • Bio Products Laboratory Limited
  • LFB S.A.
  • Sanquin Blood Supply Foundation

Table Information

This website uses cookies to ensure you get the best experience. Learn more